Compliant safety

Fig. 1.4 illustrates where design codes such as FAR/CS25.1309 are positioned in the regulatory regime and some of the advisory materials available to support the generation of a compliant Safety Assessment. 

What defines comfort One executive surveyed said, Proper fit and giving workers alternatives that work best for them is important. Another said, Compliant safety wear must be affordable, comfortable and durable — all at the same time. We look at price, quality and product features that serve our exact purpose on the job. ... 

Side protection ANSI Z87 compliant safety glasses vary dramatically in the amount of side protection provided. When I inspected a number of designs on the market, I was surprised to find that some styhsh designs, while looking good, offered limited side protection, while other well-designed glasses provided as much as additional side protection beyond the ANSI specification. (See photo.)... 

Concomitant or prior medications may be used in either safety or efficacy analyses. The presence of specific medications may be used as covariates for inferential analyses. Also, medications are often summarized to show that the therapies under study come from medically comparable populations. Medications may be used to determine protocol compliance and to help define a protocol-compliant study population. Concomitant medications may be examined to determine whether they interact with study therapy or whether they can explain the presence of certain adverse events. From a CDISC perspective, prior medications would be considered a finding while concomitant medications would be considered an intervention. 

We chose Level 2 as the reference level during our analysis that means that by safe we understand that the system is compliant with the railway safety regulations. And we chose Level 6 as the lowest component level (we did not consider further decomposition levels). Our goal was to analyse how possible failure modes of the components can affect the safety properties expressed with respect to Level 2. 

Prior to beginning development, many sponsors would also have conducted in vitro safety pharmacology studies (e.g., hERG inhibition) to assess cardiovascular concerns, as well as single-dose and 5- to 7-day repeated-dose non-GLP-compliant studies to assess toxicity and help set doses for the GLP-compliant studies (see Table 7.3). 

The design and construction of isolators should be carried out in an appropriate quality-assured way because the devices are frequently complex and require a high level of documentation to comply with both safety and good quality requirements. ISO 9000 compliant or similar quality assurance systems provide an appropriate management environment in which to design and build systems destined for quality or safety critical applications. 

The aim of this chapter is to describe the general framework for conducting good clinical practices (GCP)-compliant clinical research. As it is difficult to cover this broad topic in such a short chapter, the authors will focus on those areas that are most discussed, most problematic and most critical to achieving a GCP-compliant clinical study. Thus, there is particular emphasis on ethical issues, source data verification and data integrity, monitoring and safety review, and study medication/device management. 

---